# ABBVIE INC. (ABBV)

> ABBVIE INC. (ABBV) trades at $288.84 (-2.05%) as of 7:59:14 PM EST on Nov 2, 2026, +9.90% over the past month. Market cap is $521.11B, with 2.7 days to cover in short interest.

Canonical: https://massive.com/quote/abbv
Data as of: 2026-11-03T00:59:14.646Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$288.84** -6.05 (-2.05%)
At close · 15-minute delayed
NYSE · usd

After hours: **$289.65** +0.81 (+0.28%)
As of 7:59:14 PM EST on Nov 2, 2026 · After hours

## Stock performance

How ABBVIE INC. (ABBV) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -2.05% |
| 1W | +0.73% |
| 1M | +9.90% |
| YTD | +26.41% |
| 1Y | +33.79% |
| 52-wk range | $190.75 – $298.74 |

From daily closes through Nov 2, 2026.

## Key statistics

Today's trading snapshot for ABBV: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $286.14 – $294.86 |
| Open | $290.38 |
| Prev close | $294.89 |
| Volume | 8.85M |
| Market cap | $521.11B |
| Shares out | 1.77B |

## Valuation and profitability ratios

Valuation and profitability ratios for ABBVIE INC.: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | 82.85 |
| P/S | 8.09 |
| P/B | -87.80 |
| P/FCF | 28.62 |
| ROE | -106.0% |
| ROA | 4.7% |
| Debt/Equity | -11.93 |
| Div yield | 2.30% |

As of Oct 30, 2026

## Insider trading

[ABBVIE INC. (ABBV) insider trading](https://massive.com/quote/abbv/insider-trading.md): open-market Form 4 buys and sells by ABBVIE INC. insiders over the last 12 months.

## 8-K filings

Material corporate events ABBVIE INC. has disclosed to the SEC on Form 8-K.

- Oct 30, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On October 30, 2026, AbbVie Inc. issued a press release announcing financial results for the third quarter ended September 30, 2026.”
- Oct 15, 2026 · Director appointment
  “On October 14, 2026, AbbVie Inc. ("AbbVie") expanded the size of its Board of Directors (the "Board") from twelve directors to thirteen directors and appointed Dr. John M. Carethers as a Class II director. Dr. Carethers has been appointed to the Public Policy and Sustainability Committee of AbbVie.”
- Oct 5, 2026 · [Guidance issuance or update](https://massive.com/quote/sec-filings/8-k/guidance-updates.md)
  “AbbVie's full-year 2026 adjusted diluted earnings per share guidance range, including the impact of third-quarter 2026 acquired IPR&D and milestones expense, is $13.76 - $13.96. AbbVie's third-quarter 2026 adjusted diluted earnings per share guidance range, including the impact of third-quarter 2026 acquired IPR&D and milestones expense, is $3.73 - $3.77.”
- Sep 3, 2026 · Acquisition completion
  “On September 3, 2026, AbbVie Inc. (the "Company") issued a press release announcing the completion of its acquisition of Apogee Therapeutics, Inc.”
- Aug 18, 2026 · Debt issuance
  “AbbVie completed its previously announced underwritten public offering of $500,000,000 aggregate principal amount of its senior floating rate notes due 2028, $1,000,000,000 aggregate principal amount of its 4.500% senior notes due 2028, $1,250,000,000 aggregate principal amount of its 4.650% senior notes due 2030, $1,500,000,000 aggregate principal amount of its 4.875% senior notes due 2031, $1,250,000,000 aggregate principal amount of its 5.050% senior notes due 2033, $1,500,000,000 aggregate principal amount of its 5.300% senior notes due 2036, $1,000,000,000 aggregate principal amount of its 5.450% senior notes due 2038, $1,500,000,000 aggregate principal amount of its 6.000% senior notes due 2056 and $500,000,000 aggregate principal amount of its 6.100% senior notes due 2066.”

## Dividend history and stock splits

ABBVIE INC.'s recent dividend payments and stock splits.

### Dividends

- $1.82 · ex-div Jan 15, 2027
- $1.73 · ex-div Oct 15, 2026
- $1.73 · ex-div Jul 15, 2026
- $1.73 · ex-div Apr 15, 2026

### Splits

No recent splits.

## Similar companies

Public companies in a similar business to ABBVIE INC..

- [PFE](https://massive.com/quote/pfe.md) Pfizer Inc. (+0.49%)
- [ABT](https://massive.com/quote/abt.md) Abbott Laboratories (+3.73%)
- [JNJ](https://massive.com/quote/jnj.md) Johnson & Johnson (-0.97%)
- [AMGN](https://massive.com/quote/amgn.md) Amgen Inc (-0.12%)
- [BMY](https://massive.com/quote/bmy.md) Bristol-Myers Squibb Co. (+0.86%)
- [MRK](https://massive.com/quote/mrk.md) Merck & Co., Inc. (-0.78%)
- [LLY](https://massive.com/quote/lly.md) Eli Lilly & Co. (-0.46%)
- [GILD](https://massive.com/quote/gild.md) Gilead Sciences Inc (-0.20%)

Daily change in the latest session, 15-minute delayed.

## ABBV short interest

How heavily ABBV is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 2.7 |
| Short interest | 15.58M |
| Avg volume | 5.72M |

As of Oct 15, 2026 · reported to FINRA twice monthly.

## ABBV news

The latest news and headlines about ABBVIE INC. (ABBV).

- [The Best Dividend Stocks to Buy With $5,000 in November](https://www.fool.com/investing/2026/11/02/the-best-dividend-stocks-to-buy-with-5000-in-novem/?source=iedfolrf0000001) · The Motley Fool · Nov 2, 2026 · positive sentiment
- [AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy for 2027?](https://www.fool.com/coverage/better-buy/2026/11/02/abbvie-vs-bristol-myers-squibb-which-healthcare-stock-is-a-better-buy-for-2027/?source=iedfolrf0000001) · The Motley Fool · Nov 2, 2026 · positive sentiment
- [ABBV Q3 Earnings Call Highlights Raised Outlook and Pipeline Progress](https://www.zacks.com/stock/news/3020627/abbv-q3-earnings-call-highlights-raised-outlook-and-pipeline-progress?cid=CS-ZC-FT-analyst_blog_plus|earnings_call_takeaways-3020627) · Zacks Investment Research · Nov 2, 2026 · positive sentiment
- [Prediction: AbbVie's Next Blockbuster Is Hiding in a Two-Drug Crohn's Combo](https://www.fool.com/investing/2026/11/02/prediction-abbvies-next-blockbuster-is-hiding-in-a/?source=iedfolrf0000001) · The Motley Fool · Nov 2, 2026 · positive sentiment
- [Better Dividend ETF: iShares HDV's High Yields vs. ProShares NOBL's Dividend Growth](https://www.fool.com/coverage/etfs/2026/10/31/better-dividend-etf-ishares-hdv-s-high-yields-vs-proshares-nobl-s-dividend-growth/?source=iedfolrf0000001) · The Motley Fool · Oct 31, 2026 · positive sentiment

## About ABBVIE INC.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.

| Measure | Value |
| --- | --- |
| Exchange | NYSE |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 57K |
| Listed | Dec 10, 2012 |

[Company website](https://www.abbvie.com)

## FAQ

### What is the ABBVIE INC. (ABBV) stock price today?

ABBVIE INC. (ABBV) is trading at $288.84 (-2.05% on the day) as of 7:59:14 PM EST on Nov 2, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is ABBVIE INC.?

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013.

### What is the short interest in ABBV?

As of Oct 15, 2026, ABBV has 15.58M shares short and 2.7 days to cover.

### Does ABBVIE INC. (ABBV) pay a dividend?

Yes. ABBVIE INC. (ABBV)'s most recent dividend was $1.82 per share, with an ex-dividend date of Jan 15, 2027. Full ABBV dividend history is available from the Massive API.

### What exchange is ABBV listed on?

ABBVIE INC. (ABBV) trades on NYSE in USD, in the PHARMACEUTICAL PREPARATIONS industry.

## Live data

Prices here are 15-minute delayed. For real-time ABBV quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=ABBV`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [ABBVIE INC. (ABBV) insider trading](https://massive.com/quote/abbv/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms